A Phase I Study Assessing Pharmacokinetics, Safety And Tolerability Of ONS-3010 Compared To Both The US And EU Sourced Humira Reference Products And The Two Reference Products To Each Other In Healthy Volunteers

Trial Profile

A Phase I Study Assessing Pharmacokinetics, Safety And Tolerability Of ONS-3010 Compared To Both The US And EU Sourced Humira Reference Products And The Two Reference Products To Each Other In Healthy Volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease; Psoriasis; Rheumatoid arthritis; Ulcerative colitis
  • Focus First in man; Pharmacokinetics
  • Most Recent Events

    • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 14 Nov 2016 According to an Oncobiologics media release, the data was presented at the 2016 American College of Rheumatology Annual Scientific Meeting.
    • 14 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top